, Fact or Fiction: What Healthcare Professionals Need to Know about Pharmaceutical Marketing in the European Union -Health Action International, Health Action International, 2016.
, Understanding and responding to pharmaceutical promotion: a practical guide, 2009.
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries, Int J Health Policy Manag, vol.7, pp.504-513, 2018. ,
Is transparency really a panacea?, J R Soc Med, vol.107, pp.216-223, 2014. ,
Dispositifs de transparence et régulation des conflits d'intérêts dans le secteur du médicament, Rev Fr Adm Publique, issue.1, pp.49-61, 2018. ,
, relative au renforcement de la sécurité sanitaire du médicament et des produits de santé, 2011.
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, pp.954-62, 2017. ,
, Paying for Performance in Health Care: Implications for Health System Performance and Accountability, 2014.
Factors associated with drug prescription in general practice: a multicenter cross-sectional study, Sante Publique, vol.27, pp.353-62, 2015. ,
Données mensuelles et annuelles sur les médicaments remboursés par l'Assurance Maladie ,
La rémunération sur objectif de santé publique -Bilan à 5 ans et présentation du nouveau dispositif, 1929. ,
Limitations and Misinterpretations of E-Values for Sensitivity Analyses of Observational Studies, Ann Intern Med, vol.170, p.108, 2019. ,
French administrative health care database (SNDS): The value of its enrichment. Therap, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01940381
Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses, JAMA Netw Open, vol.2, p.186007, 2019. ,
Association Between Industry Payments to Physicians and Gabapentinoid Prescribing, JAMA Intern Med, 2019. ,
Good prescribing practice, Regulating pharmaceuticals in europe: Striving for efficiency, equity and quality, pp.144-57, 2004. ,
Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data, J Med Internet Res, vol.21, p.10929, 2019. ,
Pay for performance: financial rewards without improving quality of care, Prescrire Int, vol.24, p.279, 2015. ,
P4P, téléservices, dépassements, maîtrise, le patron de la CNAM à l'offensive sur tous les fronts. Quotidien du médecin, 2012. ,
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review, PLoS Med, vol.7, p.1000352, 2010. ,
Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis, PLoS One, vol.12, p.175493, 2017. ,
Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review, BMJ Open, vol.7, p.16408, 2017. ,
Open data on industry payments to healthcare providers reveal potential hidden costs to the public, Nat Commun, vol.10, pp.1-8, 2019. ,
Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data, BMC Health Serv Res, vol.18, p.236, 2018. ,
Association of Industry Payments to Physicians With the Prescribing of Brandname Statins in Massachusetts, JAMA Intern Med, vol.176, pp.763-771, 2016. ,
Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing, Pharmacoepidemiol Drug Saf, vol.26, pp.819-845, 2017. ,
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs, PLoS One, vol.11, p.1, 2016. ,
Quelle politique pour poursuivre la diffusion des médicaments génériques?, 0199. ,
Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences, Arch Intern Med, vol.169, pp.887-93, 2009. ,
Payments to Physicians: Does the Amount of Money Make a Difference?, JAMA, vol.317, pp.1719-1739, 2017. ,
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries, JAMA Intern Med, vol.176, p.1114, 2016. ,
Physicians under the influence: social psychology and industry marketing strategies, J Law Med Ethics, vol.41, pp.665-72, 2013. ,